UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2182) 2182
Magazine Article (9) 9
Book Chapter (7) 7
Conference Proceeding (2) 2
Publication (2) 2
Dissertation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2133) 2133
science & technology (1699) 1699
life sciences & biomedicine (1686) 1686
hematinics - therapeutic use (1319) 1319
female (1154) 1154
male (1059) 1059
anemia - drug therapy (983) 983
middle aged (842) 842
hematinics - adverse effects (816) 816
hematinics - administration & dosage (781) 781
anemia (763) 763
aged (726) 726
erythropoietin - therapeutic use (641) 641
anemia - etiology (564) 564
treatment outcome (558) 558
recombinant proteins (555) 555
adult (534) 534
urology & nephrology (479) 479
epoetin alfa (471) 471
hemoglobins - metabolism (382) 382
erythropoietin (381) 381
darbepoetin alfa (358) 358
erythropoietin - adverse effects (358) 358
erythropoietin - analogs & derivatives (346) 346
erythropoietin - administration & dosage (345) 345
oncology (324) 324
risk factors (299) 299
hemoglobin (290) 290
anemia - blood (289) 289
aged, 80 and over (263) 263
anemia, iron-deficiency - drug therapy (263) 263
antineoplastic agents - adverse effects (262) 262
anemia - chemically induced (261) 261
care and treatment (252) 252
kidney failure, chronic - complications (249) 249
kidney failure, chronic - therapy (243) 243
hemoglobins - analysis (238) 238
neoplasms - drug therapy (238) 238
quality of life (234) 234
pharmacology & pharmacy (230) 230
renal dialysis - adverse effects (227) 227
time factors (223) 223
prospective studies (222) 222
retrospective studies (221) 221
iron (219) 219
renal dialysis (213) 213
general & internal medicine (210) 210
cancer (206) 206
drug administration schedule (200) 200
medicine, general & internal (192) 192
abridged index medicus (188) 188
chronic kidney disease (187) 187
dose-response relationship, drug (184) 184
neoplasms - complications (179) 179
hematology (176) 176
renal insufficiency, chronic - complications (176) 176
ferric compounds - administration & dosage (174) 174
nephrology (174) 174
medicine & public health (173) 173
blood transfusion (172) 172
hemodialysis (171) 171
drug therapy (168) 168
health aspects (167) 167
hematinics - pharmacology (158) 158
research (152) 152
adolescent (150) 150
infusions, intravenous (145) 145
anaemia (142) 142
anemia, iron-deficiency - etiology (141) 141
analysis (140) 140
anemia - therapy (140) 140
united states (139) 139
erythropoiesis - drug effects (138) 138
chronic kidney failure (137) 137
double-blind method (137) 137
ferritins - blood (137) 137
randomized controlled trials as topic (137) 137
biomarkers - blood (136) 136
chemotherapy (131) 131
practice guidelines as topic (129) 129
animals (126) 126
mortality (122) 122
anemia - complications (120) 120
iron - therapeutic use (119) 119
kidney diseases (118) 118
young adult (118) 118
ferric compounds - adverse effects (117) 117
injections, intravenous (116) 116
hematinics - economics (114) 114
nursing (114) 114
chronic disease (109) 109
iron - administration & dosage (108) 108
transplantation (107) 107
ferric compounds - therapeutic use (106) 106
kidney failure, chronic - blood (106) 106
erythropoiesis-stimulating agents (105) 105
internal medicine (103) 103
antineoplastic agents - therapeutic use (102) 102
anemia - diagnosis (101) 101
cardiovascular system & cardiology (101) 101
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2119) 2119
French (26) 26
Spanish (22) 22
German (12) 12
Hungarian (12) 12
Japanese (12) 12
Italian (11) 11
Portuguese (6) 6
Croatian (4) 4
Dutch (3) 3
Russian (3) 3
Bulgarian (1) 1
Chinese (1) 1
Czech (1) 1
Danish (1) 1
Norwegian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Kidney international, ISSN 0085-2538, 10/2015, Volume 88, Issue 4, pp. 905 - 914
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2010, Volume 28, Issue 13, pp. 2239 - 2245
Purpose To determine whether epoetin alfa reduces anemia-related fatigue, improves other aspects of health-related patient-recorded outcomes (PROs), reduces... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Procarbazine - administration & dosage | Cyclophosphamide - administration & dosage | Prospective Studies | Humans | Middle Aged | Erythropoietin - adverse effects | Male | Cyclophosphamide - adverse effects | Young Adult | Anemia - drug therapy | Time Factors | Hodgkin Disease - mortality | Vincristine - administration & dosage | Epoetin Alfa | Prednisone - adverse effects | Hematinics - therapeutic use | Risk Assessment | Erythrocyte Transfusion | Risk Factors | Etoposide - administration & dosage | Hematinics - adverse effects | Bleomycin - administration & dosage | Hodgkin Disease - blood | Procarbazine - adverse effects | Adolescent | Vincristine - adverse effects | Germany | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Anemia - blood | Erythropoietin - therapeutic use | Hodgkin Disease - pathology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Fatigue - etiology | Recombinant Proteins | Hodgkin Disease - drug therapy | Adult | Female | Anemia - etiology | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Etoposide - adverse effects | Double-Blind Method | Fatigue - drug therapy | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Bleomycin - adverse effects | Neoplasm Staging | Doxorubicin - adverse effects | Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 03/2013, Volume 368, Issue 13, pp. 1210 - 1219
In this trial, patients with systolic heart failure and anemia were assigned to receive either darbepoetin alfa or placebo. At 28 months, there was no... 
MORTALITY | CONTROLLED-TRIAL | CITY CARDIOMYOPATHY QUESTIONNAIRE | EPOETIN | MORBIDITY | REDUCTION | DOUBLE-BLIND | CHRONIC KIDNEY-DISEASE | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Shock, Septic - etiology | Double-Blind Method | Heart Failure, Systolic - drug therapy | Hematinics - therapeutic use | Erythropoietin - therapeutic use | Heart Failure, Systolic - mortality | Humans | Middle Aged | Kaplan-Meier Estimate | Proportional Hazards Models | Erythropoietin - adverse effects | Hematinics - adverse effects | Male | Thromboembolism - etiology | Erythropoietin - analogs & derivatives | Stroke - etiology | Anemia - drug therapy | Treatment Failure | Female | Aged | Darbepoetin alfa | Anemia - etiology | Hemoglobins - analysis | Heart Failure, Systolic - complications | Heart failure | Usage | Care and treatment | Anemia | Patient outcomes | Diagnosis | Clinical trials | Patient safety | Hemoglobin | Thromboembolism | Patients | Heart diseases | Cancer | Index Medicus | Abridged Index Medicus | Shock | Systolic/mortality | Hematinics/adverse effects | chronic heart failure | Erythropoietin/analogs & derivatives | Thromboembolism/etiology | Klinisk medicin | Heart Failure | Anemia/drug therapy | Hematinics/therapeutic use | Erythropoietin/therapeutic use | Hemoglobins/analysis | Anemia/etiology | Erythropoietin/adverse effects | Stroke/etiology | Clinical Medicine | Systolic/complications | Septic/etiology | Systolic/drug therapy
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 05/2017, Volume 317, Issue 20, pp. 2097 - 2104
Journal Article
The New England journal of medicine, ISSN 1533-4406, 01/2019, Volume 380, Issue 5, pp. 447 - 458
Journal Article
American journal of nephrology, ISSN 0250-8095, 2019, Volume 49, Issue 4, pp. 271 - 280
Journal Article